| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/09/1994 | EP0585366A1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 03/09/1994 | EP0585267A1 Herpesvirus particles and vaccine |
| 03/09/1994 | EP0585242A1 Wound healing |
| 03/09/1994 | EP0420914B1 Cosmetic and skin treatment compositions |
| 03/09/1994 | EP0262207B1 Beta-lactam antibiotics |
| 03/09/1994 | CN1083486A Heteroatoms-containing tricyclic compounds |
| 03/09/1994 | CN1083485A Benzothiazepine and benzoxazepine derivatives |
| 03/09/1994 | CN1083473A Novel compounds |
| 03/08/1994 | US5292878 17-spirofuran-3'-ylidene steroids |
| 03/08/1994 | US5292802 Collagen-polymer tubes for use in vascular surgery |
| 03/08/1994 | US5292761 Piperidine, tetrahydropyridine and pyrrolidine compounds |
| 03/08/1994 | US5292756 Novel sulfonamide fibrinogen receptor antagonists |
| 03/08/1994 | US5292745 Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 03/08/1994 | US5292735 Cyclic amide derivatives |
| 03/08/1994 | US5292362 Tissue bonding and sealing composition and method of using the same |
| 03/08/1994 | CA1327601C Phenoxyalkylcarboxylic acid derivatives and process for their preparations |
| 03/08/1994 | CA1327588C Leukotriene antagonists |
| 03/08/1994 | CA1327579C Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines |
| 03/08/1994 | CA1327529C Dental composition and a process for the preparation thereof |
| 03/08/1994 | CA1327524C Prostaglandins for use in medicine |
| 03/04/1994 | CA2484248A1 Excitatory amino acid receptor antagonists |
| 03/03/1994 | WO1994004694A1 Endothelial lineage specific transcriptional regulatory element from tek |
| 03/03/1994 | WO1994004686A1 Tat-derived transport polypeptides |
| 03/03/1994 | WO1994004678A1 Immunoglobulins devoid of light chains |
| 03/03/1994 | WO1994004674A1 Human melanocyte stimulating hormone receptor |
| 03/03/1994 | WO1994004671A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | WO1994004554A1 ANDROST-4-ENO[4,5-b]PYRROLE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
| 03/03/1994 | WO1994004536A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 03/03/1994 | WO1994004533A1 Condensed indole derivatives as 5ht2c and 5ht2b antagonists |
| 03/03/1994 | WO1994004531A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 03/03/1994 | WO1994004518A1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
| 03/03/1994 | WO1994004508A1 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | WO1994004495A1 Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 03/03/1994 | WO1994004494A1 Tachykinin antagonists |
| 03/03/1994 | WO1994004178A1 Method of inhibiting cell proliferation using apolipoprotein e |
| 03/03/1994 | WO1994004172A1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences |
| 03/03/1994 | WO1994004165A1 Antiangiogenic oligomers |
| 03/03/1994 | WO1994004164A1 Antiproliferative oligomers |
| 03/03/1994 | WO1994004163A1 Novel glucan preparation |
| 03/03/1994 | WO1994004161A1 Use of inhibitors of vacuolar-type h+ atpases |
| 03/03/1994 | WO1994004159A2 Treatment of cancer with azt and alkylating or intercalating agents |
| 03/03/1994 | WO1994004147A1 Method for destroying or inhibiting growth of unwanted cells or tissues |
| 03/03/1994 | WO1994004122A2 Use of diacylglycerols for increasing the melanin content in melanocytes |
| 03/03/1994 | WO1994004120A2 Methods of treating sexual dysfunction in animals with and h agonist |
| 03/03/1994 | WO1994004030A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 03/03/1994 | DE4229166A1 Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse Means for maintaining and / or increasing muscle performance and body cell mass |
| 03/03/1994 | DE4228552A1 Diphosphonsäuren und deren Salze enthaltende Arzneimittel Diphosphonic acids and their salts, pharmaceutical compositions containing them |
| 03/03/1994 | CA2143336A1 Tissue specific transcriptional regulatory element |
| 03/03/1994 | CA2143306A1 Methods and therapeutic compositions for treating cystic fibrosis |
| 03/03/1994 | CA2143003A1 Use of diacylolycerols for increasing the melanin content in melanocytes |
| 03/03/1994 | CA2142875A1 The use of h2 and h3 agonists to treat sexual dysfunction |
| 03/03/1994 | CA2142839A1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences |
| 03/03/1994 | CA2142721A1 Condensed indole derivatives as 5ht and 5ht antagonists |
| 03/03/1994 | CA2142711A1 Method for destroying or inhibiting growth of unwanted cells or tissues |
| 03/03/1994 | CA2142455A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 03/03/1994 | CA2142313A1 Use of inhibitors of vacuolar-type h atpases |
| 03/03/1994 | CA2142110A1 Antiangiogenic oligomers |
| 03/03/1994 | CA2141598A1 Method of inhibiting cell proliferation using apolipoprotein e |
| 03/03/1994 | CA2140865A1 Antiproliferative oligomers |
| 03/03/1994 | CA2140640A1 Tachykinin antagonists |
| 03/03/1994 | CA2138521A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 03/03/1994 | CA2136842A1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
| 03/03/1994 | CA2136838A1 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | CA2120726A1 Androst-4-eno¬4,5-b|pyrrole derivatives and process for their preparation |
| 03/02/1994 | EP0585206A1 Tryptamines for treatment of circadian rhythm disorders |
| 03/02/1994 | EP0585168A2 Composition and methods for the generation of bone |
| 03/02/1994 | EP0585116A1 1-Alkoxy-naphthalene-2-carboxamide derivatives with high affinity for the serotonin 5-HT1A receptor |
| 03/02/1994 | EP0585058A1 Pharmaceutical compositions containing fatty acids and heparin |
| 03/02/1994 | EP0585057A1 Lithium salts of fatty acids for the treatment of viral infections and cancer |
| 03/02/1994 | EP0585027A1 Use of fatty acids for treating abnormal tissue calcification |
| 03/02/1994 | EP0585026A1 Use of fatty acids for increasing gut calcium absorption |
| 03/02/1994 | EP0584952A1 Improvements in or relating to benzothiophenes |
| 03/02/1994 | EP0584552A2 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
| 03/02/1994 | EP0584285A1 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 03/02/1994 | EP0584283A1 Osteoinductive protein mixtures and purification processes |
| 03/02/1994 | EP0584264A1 D-type cyclin and uses related thereto |
| 03/02/1994 | EP0584250A1 Novel composition of angiotensin-ii receptor antagonists and calcium channel blockers |
| 03/02/1994 | EP0584238A1 INHIBITOR OF NF-$g(k)B TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF |
| 03/02/1994 | EP0584229A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |
| 03/02/1994 | EP0584223A1 Novel immunosuppressive compounds |
| 03/02/1994 | EP0584208A1 Pyrrolidinones |
| 03/02/1994 | EP0584185A1 Treatment of fatigue syndrome with cholinesterase inhibitors |
| 03/02/1994 | EP0584159A1 Nutrient preparation. |
| 03/02/1994 | EP0584148A1 Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent |
| 03/02/1994 | EP0584068A1 Method and composition for ameliorating the adverse effects of aging |
| 03/02/1994 | EP0584062A1 Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins |
| 03/02/1994 | EP0527787B1 Method of predisposing mammals to accelerated tissue repair |
| 03/02/1994 | EP0505414B1 Killing of activated lymphocytes |
| 03/02/1994 | EP0494916B1 Feed additive for poultry and poultry feed |
| 03/02/1994 | EP0378604B1 1,1-dioxo-cephem-4-carbothiolic acid derivatives |
| 03/02/1994 | EP0266419B1 Fibrinolytic composition |
| 03/02/1994 | CN1083074A Peptide compounds |
| 03/02/1994 | CN1083062A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 03/02/1994 | CN1083059A 3-piperidinylmethylcarboxylate substituted indoles |
| 03/02/1994 | CN1083055A Pharmaceuticals |
| 03/02/1994 | CN1083052A Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| 03/02/1994 | CN1023895C Preparation method for N-aralkyl piperidinemethanol derivatives |
| 03/02/1994 | CA2103974A1 Pyrrolidine derivatives |
| 03/01/1994 | US5290951 Intermediates useful in preparing propenone oxime ethers |